Greece vs Portugal: Cause of death, by non-communicable diseases, ages 15-59, male
Greece
71.0%
in 2021
Portugal
70.2%
in 2021
Greece rank
31st
Portugal rank
33rd
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Greece
- Portugal
How they compare
Greece currently reports 71.0% against 70.2% in Portugal, a difference of 0.8%.
Across all 6 years both countries report, Greece has been ahead every year.
Greece ranks 31st and Portugal ranks 33rd of 185 countries.
Greece has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Greece | Portugal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 74.7% | 66.1% | 8.6% | Greece |
| 2010s | 79.2% | 75.8% | 3.4% | Greece |
| 2020s | 74.1% | 70.7% | 3.5% | Greece |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Greece or Portugal?
- Greece, at 71.0% against 70.2% in Portugal as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Greece and Portugal?
- 0.8%, with Greece ahead.
- How many years of comparable data are there for Greece and Portugal?
- 6 years are reported by both, from 2000 to 2021.
- How do Greece and Portugal rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Greece ranks 31st and Portugal ranks 33rd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.